ATP5J expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.676000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.243760E-01
Normal-vs-Stage2
9.965400E-01
Normal-vs-Stage3
8.110000E-01
Normal-vs-Stage4
3.173000E-01
Stage1-vs-Stage2
7.083400E-03
Stage1-vs-Stage3
3.112000E-01
Stage1-vs-Stage4
1.034420E-02
Stage2-vs-Stage3
6.090400E-01
Stage2-vs-Stage4
2.985600E-01
Stage3-vs-Stage4
4.158600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.498200E-01
Normal-vs-AfricanAmerican
6.618400E-01
Normal-vs-Asian
9.763400E-01
Caucasian-vs-AfricanAmerican
6.719000E-01
Caucasian-vs-Asian
6.774400E-01
AfricanAmerican-vs-Asian
5.581600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.436400E-01
Normal-vs-Female
7.814800E-01
Male-vs-Female
4.275400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.471600E-01
Normal-vs-Age(41-60Yrs)
7.284000E-01
Normal-vs-Age(61-80Yrs)
9.855800E-01
Normal-vs-Age(81-100Yrs)
3.756600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.744600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.293000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.427400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.094600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.003000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.409020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.592600E-01
Normal-vs-Daily Drinker
8.239000E-01
Normal-vs-Weekly Drinker
8.717000E-01
Normal-vs-Occasional Drinker
9.842000E-01
Normal-vs-Social Drinker
9.751400E-01
Non Drinker-vs-Daily Drinker
3.960200E-01
Non Drinker-vs-Weekly Drinker
9.683200E-01
Non Drinker-vs-Occasional Drinker
7.595800E-01
Non Drinker-vs-Social Drinker
7.548600E-01
Daily Drinker-vs-Weekly Drinker
4.904800E-01
Daily Drinker-vs-Occasional Drinker
6.539400E-01
Daily Drinker-vs-Social Drinker
6.231200E-01
Weekly Drinker-vs-Occasional Drinker
8.200200E-01
Weekly Drinker-vs-Social Drinker
7.991800E-01
Occasional Drinker-vs-Social Drinker
9.949200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.084600E-01
Normal-vs-Grade 2
2.784800E-01
Normal-vs-Grade 3
3.222600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.516000E-01
Grade 1-vs-Grade 3
2.459600E-01
Grade 1-vs-Grade 4
3.084600E-01
Grade 2-vs-Grade 3
4.306600E-01
Grade 2-vs-Grade 4
2.784800E-01
Grade 3-vs-Grade 4
3.222600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.822000E-01
Normal-vs-NonDiabetic
8.233200E-01
Diabetic-vs-NonDiabetic
2.503000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.507400E-01
Normal-vs-NoPancreatitis
9.425200E-01
Pancreatitis-vs-NoPancreatitis
2.130400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.575600E-01
Normal-vs-N1
9.872800E-01
N0-vs-N1
2.893700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.771200E-01
Normal-vs-TP53-NonMutant
7.829600E-01
TP53-Mutant-vs-TP53-NonMutant
9.526000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
